Clinical trial
Osteoporosis Prevention With Low Dose Alendronate
NCT00463268 · University Hospital of Mont-Godinne, Other · Completed
Key facts
| NCT number | NCT00463268 |
|---|---|
| Title | Osteoporosis Prevention With Low Dose Alendronate |
| Official title | Prevention of Postmenopausal Bone Loss in Osteopenic Women With Alendronate Given on a 70 mg Once-every Two Week Regimen: a 2-year, Double-blind, Placebo-controlled Clinical Trial. |
| Lead sponsor | University Hospital of Mont-Godinne, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Osteopenia |
| Intervention type | Dietary Supplement, Drug |
| Interventions | alendronate, Calcium/Vitamin D, placebo |
| Enrollment | 83 |
| Start date | Sep 1, 2007 |
| Primary completion | Jan 1, 2012 |
| Completion | Jan 1, 2012 |
| First posted | Apr 20, 2007 |
| Last update posted | May 29, 2013 |
| Countries | Belgium |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: